Pharmaceutical Statistics

Papers
(The H4-Index of Pharmaceutical Statistics is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Frailty model with change points for survival analysis37
Using an early outcome as the sole source of information of interim decisions regarding treatment effect on a long‐term endpoint: The non‐Gaussian case24
Generalizing Treatment Effect to a Target Population Without Individual Patient Data in a Real‐World Setting18
A Bayesian method for safety signal detection in ongoing blinded randomised controlled trials18
Pre‐Posterior Distributions in Drug Development and Their Properties18
Improved inference forMCP‐Modapproach using time‐to‐event endpoints with small sample sizes18
A Likelihood Perspective on Dose‐Finding Study Designs in Oncology17
Average Hazard as Harmonic Mean16
15
Estimators for handling COVID‐19‐related intercurrent events with a hypothetical strategy15
Weighted log‐rank test to compare two survival functions in the presence of dependent censoring14
A conservative approach to leveraging external evidence for effective clinical trial design13
Applying the Estimand Framework to Non‐Inferiority Trials13
A meta‐analytic framework to adjust for bias in external control studies13
Information‐based group sequential design for post‐market safety monitoring of medical products using real world data13
0.080640077590942